| Home > Publications database > Stereoselective Two-Step Biocatalysis in Organic Solvent: Toward All Stereoisomers of a 1,2-Diol at High Product Concentrations |
| Typ | Amount | VAT | Currency | Share | Status | Cost centre |
| Hybrid-OA | 1790.75 | 0.00 | EUR | 100.00 % | (Zahlung erfolgt) | E41.402.02 |
| Sum | 1790.75 | 0.00 | EUR | |||
| Total | 1790.75 |
| Journal Article | FZJ-2017-00282 |
; ;
2016
ACS Publ.
Washington, DC
This record in other databases:
Please use a persistent id in citations: doi:10.1021/acs.oprd.6b00232
Abstract: Biotransformations on larger scale are mostly limited to cases in which alternative chemical routes lack sufficient chemo-, regio-, or stereoselectivity. Here, we expand the applicability of biocatalysis by combining cheap whole cell catalysts with a microaqueous solvent system. Compared to aqueous systems, this permits manifoldly higher concentrations of hydrophobic substrates while maintaining stereoselectivity. We apply these methods to four different two-step reactions of carboligation and oxidoreduction to obtain 1-phenylpropane-1,2-diol (PPD), a versatile building block for pharmaceuticals, starting from inexpensive aldehyde substrates. By a modular combination of two carboligases and two alcohol dehydrogenases, all four stereoisomers of PPD can be produced in a flexible way. After thorough optimization of each two-step reaction, the resulting processes enabled up to 63 g L–1 product concentration (98% yield), space-time-yields up to 144 g L–1 d–1, and a target isomer content of at least 95%. Despite the use of whole cell catalysts, we did not observe any side product formation of note. In addition, we prove that, by using 1,5-pentandiol as a smart cosubstrate, a very advantageous cofactor regeneration system could be applied.
|
The record appears in these collections: |